Tredegar (TG) Q2 2024 earnings summary

Executive summary

• Net income for Q2 2024 was $8.8M ($0.26 per diluted share), a significant improvement from a net loss of $18.9M ($-0.56 per share) in Q2 2023, driven by higher EBITDA across all segments and the absence of prior year goodwill impairment.

• Ongoing operations net income was $10.3M ($0.30/share) vs. a loss of $2.0M ($-0.06/share) year-over-year.

• EBITDA from ongoing operations improved sequentially and year-over-year in all segments, with PE Films and Flexible Packaging Films rebounding from prior losses.

• Management highlighted a recovery from prior year losses, with positive trends in order volumes and a focus on cost control, working capital, and capital spending.

Financial highlights

• Q2 2024 sales were $190.2M, up from $178.2M in Q2 2023; six-month sales were $366.0M, slightly down from $369.3M year-over-year.

• Gross profit margin rose to 18.1% in Q2 2024 from 9.9% in Q2 2023; six-month margin was 16.8% vs. 11.7% prior year.

• Consolidated EBITDA from ongoing operations was $22.6M in Q2 2024 vs. $7.4M in Q2 2023; six-month EBITDA was $39.7M vs. $20.7M.

• Q2 2024 EPS was $0.26 (basic and diluted) vs. $(0.56) in Q2 2023; six-month EPS was $0.35 vs. $(0.59) prior year.

• Net debt at June 30, 2024 was $133.3M, up slightly from $132.8M at year-end 2023.

Outlook and guidance

• Management expects PE Films' EBITDA to moderate in Q3 2024 as customer inventories stabilize after restocking.

• The sale of Terphane is pending regulatory approval in Brazil, with a decision deadline of November 18, 2024; expected after-tax proceeds are $85M.

• Capital expenditures for 2024 are projected at $9M for Aluminum Extrusions, $2M for PE Films, and $4M for Flexible Packaging Films.

• Final determinations on U.S. duties for aluminum extrusions are expected by end of Q3 2024, potentially aiding market share recovery.